Searching For Value In A Plunging Market: GlaxoSmithKline plc & Ted Baker plc Stand Out

Royal Mail PLC (LON:RMG), Aviva plc (LON:AV), GlaxoSmithKline plc (LON:GSK), Ted Baker plc (LON:TED) & Rentokil Initial plc (LON:RTO) are under the spotlight.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

cityMarket fear is back. So, which shares could buck the trend in a declining market? 

5 Names On The Radar

The shares of Royal Mail Group (LSE: RMG) and Aviva (LSE: AV) outperformed those of more cyclical businesses on Wednesday, when volatility began to rise, yet they gave up their gains on Thursday. GlaxoSmithKline (LSE: GSK) fared better than others and is worth a look. Its stock has proved resilient in the last couple of days of trading: it may have bottomed out. Ted Baker (LSE: TED) and Rentokil (LSE: RTO), meanwhile, also got my attention.

Looking For A Defensive Play

As market volatility springs back, it’s an uphill struggle for investors who must preserve returns to the end of the year. The VIX Index almost reached 18 on Thursday. Above 20, it’s not going to be a nice day in the office. Banks, food retailers, utilities, oil producers and miners have come under intense pressure, as one would expect.

In the last two trading sessions, the FTSE 100 index has lost more than 2.5% of value. Only a few shares have been holding up relatively well. That’s the case of GSK stock, for instance. Why so?

One reason is that the stock is not expensive. Another reason is that both opportunistic traders and value investors seem willing to bet on GSK at this level. Ted Baker, though, remains my favourite pick when it comes to value. 

Royal Mail: An Opportunistic Trade

Opportunistic traders may be attracted to Royal Mail stock, given that it trades around the lows for the year (390p).

If recent trends are anything to go by, the shares of Royal Mail may trade in the 390p-450p range until the end of 2014, yet this is a bet for traders who want to make a quick buck. Royal Mail promises a decent yield, but its stock looks a lot like an overpriced bond, even at this price.

In its current form, I don’t think Royal Mail is a value proposition, although it may offer plenty of upside if management were willing to engineer a break-up. Unfortunately, that doesn’t seem a likely option at present. Trading multiples suggest that the shares are fully valued.

Aviva & GSK & Others: Are Steady Returns On The Cards?

I wouldn’t invest in the insurance sector right now, but I have been impressed by Aviva’s management in recent times. Not only are managers are pursuing efficiency; they may be able to grow the business in the next couple of years. The equity valuations of Aviva’s competitors aren’t particularly attractive, and Aviva promises to be a more stable investment than others. These are elements to like.

At GSK, meanwhile, management must regain pride. Yes, its shares are cheap by most metrics. And yes, its shares offer more value than those of rivals. Trust has gone out of the window, however. A positive trading update, or a large M&A deal, would be needed to boost confidence. In short, GSK is certainly a defensive bet offering a decent yield, and perhaps capital gains, but it should do more to become a stellar performer.

Operating on a different scale, and in a different sector, Rentokil could also create value for shareholders if management were fast to divest unwanted assets. Finally, here’s a company that offers plenty of value: Ted Baker. Management are showing how business is done in tough trading conditions. Strong results this week helped the stock rise in a declining market.

For me, Ted stock is still a buy at this level.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be considered so you should consider taking independent financial advice.

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

Using the price-to-earnings metric to find the cheapest UK shares to buy now!

There’s certainly no shortage of value UK shares right now. I'm finding the cheapest stocks for my portfolio using the…

Read more »

Man changing battery on electric bicycle
Investing Articles

Stock market recovery: my top 2 FTSE 100 shares to buy this month!

The UK index might be trading above 7,500, but many FTSE 100 shares still haven't recovered. In fact, plenty trade…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

4 of my best shares to buy for an autumn stock market bounce

Jon Smith explains which are his best shares to buy depending on different scenarios behind a potential market rally.

Read more »

Risk reward ratio / risk management concept
Investing Articles

Is the GSK share price good value after the 13% fall last week?

Jon Smith considers the reason behind the sharp fall in the GSK share price last week, and wonders if now…

Read more »

Young black woman in a wheelchair working online from home
Investing Articles

At under 5p, are Woodbois shares a no-brainer buy now?

I didn't buy Woodbois shares when they were up over 8p. Now they've fallen back, I'm wondering if I'm seeing…

Read more »

Business development to success and FTSE 100 250 350 growth concept.
Investing Articles

Are we about to see a raging bull market for shares?

Investor sentiment looks like it's changing and we could be in the early stages of a bull market for shares…

Read more »

Black father holding daughter in a field of cows
Investing Articles

I’m investing just £5 a day in income stock to aim for £8,000 a year in passive revenue!

Income stocks form the core part of my portfolio, offering me passive income with minimal effort. But I'm reinvesting my…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

3 dividend hero stocks for a monthly passive income

This Fool discusses the investment trusts capable of paying him a lifetime of growing passive income to supplement his portfolio…

Read more »